Legend Biotech Corporation
LEGN
$19.01
-$0.33-1.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -239.70M | -325.33M | -218.15M | -177.03M | -348.13M |
| Total Depreciation and Amortization | 23.52M | 21.55M | 21.07M | 21.59M | 19.90M |
| Total Amortization of Deferred Charges | 206.00K | 206.00K | 206.00K | 206.00K | 454.00K |
| Total Other Non-Cash Items | 187.95M | 253.74M | 119.76M | 29.75M | 118.88M |
| Change in Net Operating Assets | -142.05M | -224.86M | -186.19M | -18.55M | 51.30M |
| Cash from Operations | -170.07M | -274.70M | -263.31M | -144.03M | -157.60M |
| Capital Expenditure | -18.61M | -15.67M | -9.86M | -14.11M | -16.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.88M | 348.02M | -187.89M | -836.44M | -339.12M |
| Cash from Investing | -16.73M | 332.35M | -197.76M | -850.54M | -355.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.58M | -4.14M | -4.04M | -4.02M | -2.78M |
| Issuance of Common Stock | 3.59M | 7.73M | 9.57M | 9.72M | 9.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.00K | 3.59M | 5.53M | 5.70M | 6.96M |
| Foreign Exchange rate Adjustments | 6.40M | 4.09M | -342.00K | -2.09M | 1.64M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.38M | 65.33M | -455.87M | -990.96M | -504.19M |